gadolinium has been researched along with gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate in 170 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (9.41) | 18.7374 |
| 1990's | 71 (41.76) | 18.2507 |
| 2000's | 30 (17.65) | 29.6817 |
| 2010's | 41 (24.12) | 24.3611 |
| 2020's | 12 (7.06) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, RD; Brucher, E; Geraldes, CF; Koenig, SH; Sherry, AD; Spiller, M | 1 |
| Gevenois, PA; Salmon, I; Simon, J; Sintzoff, SA; Stallenberg, B; Struyven, J; Van Regemorter, G | 1 |
| Armspach, JP; Chambron, J; Mauss, Y; Namer, IJ; Poulet, P; Steibel, J | 1 |
| Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
| Kumar, K; Tweedle, MF; Wedeking, P | 2 |
| Bollinger, A; Duewell, S; Fuchs, WA; Hagspiel, KD; von Schulthess, GK; Zuber, J | 1 |
| Marincek, B; McPhillips, M; Thurnher, S; von Schulthess, GK | 1 |
| Attlan, E; Denys, A; Hanna, S; Hélénon, O; Kreis, H; Legendre, C; Moreau, JF; Souissi, M | 1 |
| Brugieres, P; Chevalier, X; Ducou le Pointe, H; Gaston, A; Meder, JF; Voisin, MC | 1 |
| Duda, SW; Katzberg, RW; McKenna, BA; Morris, TW; Niedrach, WL; Pabico, RC; Sahler, LG; Tonetti, FW | 2 |
| Ekholm, SE; Leakey, P; Marinetti, GV; Morris, TW; Prentice, LI | 1 |
| Chambon, C; Doucet, D; Frija, G; Kravtzoff, R; Ropars, C; Schoumann-Claeys, E; Urvoas, E | 1 |
| Beaute, S; Doucet, D; Meyer, D; Schaefer, M | 1 |
| Koenig, SH | 1 |
| Gelblum, DY; Jacobson, S; Runge, VM | 1 |
| Baumelou, B; Bellin, MF; Boulechfar, H; Deray, G; Grellet, J; Jacobs, C; Rey, JP | 1 |
| Bataillard, M; Christmann, D; Dietemann, JL; Kurtz, D; Romero, C | 1 |
| Björkengren, AG; Geborek, P; Holtås, S; Petterson, H; Rydholm, U | 1 |
| Demaerel, P; Marchal, G; Wilms, G | 1 |
| Hodler, J; Marincek, B; Orellano, J; Thurnher, S; von Schulthess, GK | 1 |
| Gries, H; Press, WR; Weinmann, HJ | 1 |
| Ahkong, QF; Fritz, T; Tilcock, C; Unger, E | 1 |
| Bonnet, PA; Boucard, M; Chapat, JP; Cyteval, C; Fernandez, JP; Lamarque, JL; Michel, A; Rifai, A | 1 |
| Bonnemain, B; Chambon, C; Davies, R; Le Mignon, MM; Warrington, S | 1 |
| Stark, DD; Weissleder, R | 1 |
| Adelman, LS; Jacobson, S; Kaufman, DM; Runge, VM; Wood, ML | 1 |
| Baert, AL; Decrop, E; Marchal, G; Plets, C; Wilms, G | 1 |
| Baert, AL; Decrop, E; Marchal, G; Van Hecke, P; Wilms, G | 1 |
| Allard, M; Bonnemain, B; Caillé, JM; Meyer, D; Simonnet, G | 1 |
| Allard, M; Bonnemain, B; Caille, JM; Kien, P; Simonnet, G | 1 |
| Fischer, H; Maton, F; Muller, RN; Rinck, PA; Roch, A; Vallet, P; Van Haverbeke, Y; Vander Elst, L | 1 |
| Bonnemain, B; Meyer, D; Schaefer, M | 1 |
| Coffre, C; Contesso, G; Masselot, J; Sarrazin, D; Vanel, D | 1 |
| Tweedle, M; Wedeking, P | 1 |
| Bousquet, JC; Ferrucci, JT; Hahn, PF; Nigam, M; Saini, S; Stark, DD; Wittenberg, J | 1 |
| Bennett, HF; Brasch, RC | 1 |
| Belleville, J; Corot, C; Eloy, R; Paul, J | 1 |
| Adelman, LS; Jacobson, S; Kaufman, D; Runge, VM; Wood, ML | 1 |
| Allard, M; Bonnemain, B; Caille, JM; Doucet, D; Kien, P; Simonnet, G | 1 |
| Baltzer, L; Brechbiel, MW; Colcher, D; Gansow, OA; Girton, ME; Knop, RH; Magerstädt, M; Naegele, M | 1 |
| Brugières, P; Combes, C; Gaston, A; Gray, F; Houhou, S; Ricolfi, F; Sadik, JC; Thomas, P | 1 |
| Gueye, C; Laissy, JP; Scherrer, A; Somveille, E; Soyer, P | 1 |
| Brunnschweiler, H; Hagberg, G; Kappos, L; Mader, I; Radue, EW; Roser, W; Seelig, J | 1 |
| Dommisse, R; Lanens, D; Oksendal, A; Spanoghe, M; Van Audekerke, J; Van der Linden, A | 1 |
| Corot, C; Curtelin, L; Hentsch, AM | 1 |
| Laissy, JP; Menu, Y; Sibert, A; Soyer, P; Tidjani, K | 1 |
| Clarisse, J; Dewailly, D; Fossati, P; Hamon-Kérautret, M; Leclerc, X; Pruvo, JP | 1 |
| Derugin, N; Higgins, CB; Lauerma, K; Roberts, TP; Saeed, M; Varadarajan, J; Watson, AD; Wendland, MF; Yu, KK | 1 |
| Amiel, M; Cordier, JF; Douek, PC; Revel, D; Simoni, L | 1 |
| Berenyi, E; Bogner, P; Geraldes, CF; Kiefer, GE; Lázár, I; Maton, F; McMillan, K; Miseta, A; Sherry, AD; Sumegi, B | 1 |
| Nidecker, A | 1 |
| Goudemant, JF; Muller, RN; Van Haverbeke, Y; Vander Elst, L | 1 |
| Achour, E; Azencot, M; Hercot, O; Laissy, JP; Marmuse, JP; Menu, Y; Sibert, A; Soyer, P; Vissuzaine, C | 1 |
| Amiel, M; Delignette, A; Douek, P; Loubeyre, P; Revel, D | 1 |
| Dommisse, R; Lanens, D; Spanoghe, M; Van Audekerke, J; Van der Linden, A | 1 |
| Krestin, GP; Müller, MF; Willi, UV | 1 |
| Kievit, HC; Merchant, TE; Sikkenk, AC; Thelissen, GR | 1 |
| Casselman, JW; D'Hont, G; De Clercq, C; De Jonge, I; Neyt, L | 1 |
| Anglade, MC; Dao, TH; Divine, M; Golli, M; Jazaerli, N; Mathieu, D; Rahmouni, A; Reyes, F; Vasile, N | 1 |
| Anglade, MC; Dao, T; Divine, M; Golli, M; Haioun, C; Mathieu, D; Rahmouni, A; Reyes, F; Vasile, N | 1 |
| De Schepper, AM; Delaporte, C; Forton, GE; Martin, JJ; Mulkens, TH; Parizel, PM; van de Heyning, PH | 1 |
| Debatin, JF; Huch Böni, RA; Krestin, GP | 1 |
| Deimling, M; Gückel, C; Schnabel, K; Steinbrich, W | 1 |
| Bittoun, J; Drapé, JL; Goettmann, S; Guérin-Surville, H; Idy-Peretti, I | 1 |
| Böni, RA; Debatin, JF; Jochum, W; Krestin, GP; Romanowski, B; Sulser, T | 1 |
| Nowak, PJ; Oudkerk, M; Sijens, PE; van den Bent, MJ; van Dijk, P | 1 |
| Gouhiri, M; Mosnier, H; Rondeau, Y; Scherrer, A; Soyer, P; Spelle, L | 1 |
| Beauté, S; Bénizé, V; Bourrinet, P; Corot, C; Meyer, D; Sabatou, M; Schaefer, M; Zehaf, S | 1 |
| Bongartz, G; Bremerich, J; Buser, P; Grädel, C; Müller-Brand, J; Pfisterer, M; Steinbrich, W | 1 |
| Berthommier, C; Bonnemain, B; Corot, C; Goulas, V; Hermine, C; Idée, JM; Santus, R; Schaefer, M | 1 |
| Hayashi, N; Kawaguchi, T; Kawamura, J; Kobayashi, S; Nakagawa, T; Sakuma, H; Shiraishi, T; Takeda, K; Tochigi, H; Yanagawa, M | 1 |
| Caduff, RF; Debatin, JF; Garzoli, E; Kacl, G; Krestin, GP; Liu, PF | 1 |
| Aime, S; Gasco, MR; Morel, S; Terreno, E; Ugazio, E | 1 |
| Bigot, JM; Chopier, J; Frey, I; Khalil, A; Le Blanche, A; Le Breton, C; Lefkopoulos, A; Perrot, N | 1 |
| Laurent, S; Muller, RN; Vander Elst, L | 1 |
| De Schepper, AM; Declercq, A; Spanoghe, M; Van de Heyning, PH; Van den Hauwe, L; Van Marck, E | 1 |
| Gouhiri, MH; Pelage, JP; Rondeau, Y; Rymer, R; Scherrer, A; Soyer, P; Spelle, L | 1 |
| Boesiger, P; Feinle, C; Fried, M; Kunz, P; Schwizer, W | 1 |
| Brechbiel, MW; Bryant, LH; Bulte, JW; Frank, JA; Herynek, V; Wu, C | 1 |
| Ballarino, L; Caillé, JM; Canioni, P; Coussemacq, M; Delalande, C; Dousset, V; Petry, KG | 1 |
| De Jaegere, T; Landuyt, W; Loubeyre, P; Marchal, G; Miao, Y | 1 |
| Bautz, W; Dobritz, M; Fellner, C; Fellner, F; Janka, R; Lang, W; Lenz, M | 1 |
| Debatin, JF; Froehlich, J; Patak, MA; Ruehm, SG; Weishaupt, D | 1 |
| Belford, RL; Clarkson, RB; Smirnov, AI; Smirnova, TI | 1 |
| Baba, Y; Murakami, R; Onomichi, M; Takahashi, M; Yamashita, Y | 1 |
| Benderbous, S; Canet, E; Corot, C; Douek, PC; Marchand, B | 1 |
| Corot, C; Port, M; Robert, P; Violas, X | 1 |
| Bilecen, D; Haselhorst, R; Kappos, L; Möri, D; Radü, EW; Scheffler, K; Seelig, J | 1 |
| Kramann, B; Schneider, G; Seidel, R; Uder, M; Wagner, D; Weinmann, HJ | 1 |
| Bourasset, F; Bourrinet, P; Corot, C; Dencausse, A; Ducret, M | 1 |
| Corot, C; Dencausse, A; Devoldere, L; Idée, JM; Le Greneur, S; Meyer, D; Port, M; Raynal, I; Rousseaux, O; Simonot, C | 1 |
| Benderbous, S; Corot, C; Décorps, M; Dupeyre, R; Farion, R; Fonchy, E; François-Joubert, A; Lahrech, H; Rémy, C; Rubin, C | 1 |
| Dehoux, JP; Horsmans, Y; Keyeux, A; Materne, R; Peeters, F; Smith, AM; Van Beers, BE | 1 |
| Christina, H; Corot, C; Debatin, JF; Ruehm, SG; Violas, X | 1 |
| Arbab, AS; Bryant, LH; Bulte, JW; Frank, JA; Kalish, H; Lewis, BK; Miller, BR; Zywicke, HA | 1 |
| Corneillie, TM; Fisher, AJ; Meares, CF | 1 |
| Fausto, A; Iozzelli, A; Sardanelli, F | 1 |
| Annet, L; Hermoye, L; Peeters, F; Van Beers, BE | 1 |
| Barra, S; Botta, M; Chan, KW; Wong, WT | 1 |
| Dewey, M; Hamm, B; Kaufels, N; Laule, M; Raynaud, JS; Schnorr, J; Taupitz, M | 1 |
| Abe, K; Akaeda, T; Isaka, K; Kakizaki, D; Takayama, M | 1 |
| Claudon, M; Corot, C; Felblinger, J; Grenier, N; Mandry, D; Odille, F; Pedersen, M; Robert, P | 1 |
| Darrasse, L; Ginefri, JC; Poirier-Quinot, M; Robert, P | 1 |
| Birrer, M; Froehlich, JM; Huber, T; Kubik-Huch, RA; Otto, R; Seifert, B; Unterweger, M | 1 |
| Ahmad, A; Bell, J; Caussin, A; Herlihy, A; Jorgensen, MR; Kamaly, N; Keller, M; Miller, AD; Oliver, M; Perouzel, E | 1 |
| Billotey, C; Bridot, JL; Coll, JL; Elst, LV; Faure, AC; Hiba, B; Janier, M; Josserand, V; Laurent, S; Muller, R; Perriat, P; Rivière, C; Roux, S; Tillement, O | 1 |
| Barnes, T; Campbell, RS; Connolly, S; Eyes, B; Hodgson, RJ; Moots, R | 1 |
| Brasch, RC; Chaopathomkul, B; Cyran, CC; Fu, Y; Raatschen, HJ; Rogut, V; Shames, DM; Wendland, MF; Yeh, BM | 1 |
| Corot, C; Dencausse, A; Idee, JM; Medina, C; Port, M | 1 |
| Caravan, P; Chasse, JM; Deng, Q; Koerner, S; Kolodziej, AF; Looby, RJ; McMurry, TJ; Overoye-Chan, K; Zech, SG | 1 |
| Kohlmeir, EK; Meade, TJ; Song, Y | 1 |
| Bergan, RC; Dharmakumar, R; Ke, T; Lai, B; Larson, A; Li, D; Lu, ZR; Mascheri, N; Maser, J; Omary, R; Paunesku, T; Szolc-Kowalska, B; Thurn, K; Vogt, S; Woloschak, GE; Wu, A | 1 |
| Jeong, EK; Kaneshiro, TL; Lu, ZR; Morrell, G; Parker, DL | 1 |
| Barbier, EL; Beaumont, M; Farion, R; Lemasson, B; Rémy, C; Segebarth, C | 1 |
| Bousquet, PJ; Cavigioli, S; Demoly, P; Galera, C; Pur Ozygit, L | 1 |
| Arheden, H; Engblom, H; Hedström, E; Heiberg, E; Pahlm, O; Wagner, GS | 1 |
| Poe, D; Pyykkö, I; Ramadan, UA; Zhang, W; Zhang, Y; Zou, J | 1 |
| Chauvin, T; Hanefeld, U; Lukes, I; Peters, JA; Polásek, M; Schatz, J; Schühle, DT; Stuart, MC; Tóth, E | 1 |
| Brechbiel, MW; Bryant, LH; Nwe, K | 1 |
| Hsu, KC; Hu, KW; Yeh, CS | 1 |
| de Roos, A; de Zwart, IM | 1 |
| Burden, AD; Edward, M; Jardine, AG; Newton, BB; Quinn, JA | 1 |
| Bell, JD; Bunch, J; Jorgensen, MR; Kalber, TL; Kamaly, N; McLeod, CW; Miller, AD; Pugh, JA; So, PW | 1 |
| Ay, I; Benner, T; Caravan, P; Catana, C; Sorensen, AG; Uppal, R | 1 |
| Brechbiel, MW; Bryant, LH; Milenic, D; Nwe, K; Regino, CA | 1 |
| Boué, F; Bruckert, F; Combe, S; Dempsey, NM; Gaude, V; Haguet, V; Ith, A; Kauffmann, P; O'Brien, D; Reyne, G; Schaack, B | 1 |
| Pyykkö, I; Ramadan, UA; Yoshida, T; Zou, J | 1 |
| Agudelo, CA; Hurtado, AF; Iida, H; Ose, T; Tachibana, Y; Yamaoka, T | 1 |
| Fork, FT; Kadhem, S; Karlsson, N; Ohlsson, B | 1 |
| Aime, S; Baranyai, Z; Gulaka, PK; Kálmán, FK; Kodibagkar, VD; Kovács, Z; Rojas-Quijano, FA; Sherry, AD; Tircsó, G; Tircsóné Benyó, E; Tran Hoang, H | 1 |
| Chandrasekharan, P; Chuang, KH; He, T; He, Z; Liu, S; Poh, Z; Robins, EG; Yang, CT; Yong, CX | 1 |
| Bals, S; Bogomolova, A; Filippov, SK; Hruby, M; Jirak, D; Kovar, J; Kucka, J; Sedlacek, O; Stepanek, P; Turner, S; Vetrik, M | 1 |
| Chang, JC; Chien, YH; Ho, HY; Ho, WY; Huang, CC; Hung, ST; Liau, MC; Su, CH; Yeh, CS | 1 |
| Fisher, E; Reich, DS | 1 |
| Armspach, JP; de Sèze, J; Dietemann, JL; Jeantroux, J; Kremer, S; Lamy, J; Magnus, A; Oesterle, H; Trunet, S | 1 |
| Caravan, P; Jacques, V; Kolodziej, AF; Overoye-Chan, K; Zhang, Z | 1 |
| Bianchi, A; Coll, JL; Courtois, A; Crémillieux, Y; Dufort, S; Lux, F; Tillement, O | 1 |
| Al Zaki, A; Aspinwall, CA; Cheng, Z; Hall, HK; Jones, IW; Tsourkas, A | 1 |
| Chen, X; He, F; Li, E; Peng, Y; Tian, X; Yang, F; Zhu, J | 1 |
| Chang, Y; Kim, JY; Kim, KM; Kim, TJ; Ko, IO; Lee, YJ; Lim, SM; Park, JA | 1 |
| Ai, H; Deng, SL; Gao, J; Sun, C; Tang, X; Wang, L; Wu, C; Zhou, Z; Zhu, X | 1 |
| Bonnemain, B; Bruneval, P; Chevalier, T; Corot, C; Delaloge, F; Fabicki, JM; Factor, C; Fretellier, N; Idée, JM; Jestin-Mayer, G; Mayer, JF; Robic, C; Salhi, M; Schroeder, J; Siegmund, H | 1 |
| Drescher, M; Groß, A; Hartig, JS; Holder, IT; Knörr, L; Wojciechowski, F | 1 |
| Huang, CH; Mauck, RL; Nwe, K; Qu, F; Tsourkas, A; Warden-Rothman, R; Zhang, CY | 1 |
| Abdelkader, EH; Cohen, MR; Feintuch, A; Frydman, V; Goldfarb, D; Graham, B; Iron, MA; Lee, MD; Milko, P; Otting, G; Raitsimring, A; Swarbrick, JD | 1 |
| Dong, L; Du, W; Hai, Z; Liang, G; Qian, J; Xu, J; Zhong, K | 1 |
| Botteron, C; Bussi, S; Colombo Serra, S; Coppo, A; De Laurentiis, E; Fanizzi, A; Fraimbault, V; Kirchin, MA; Maisano, F; Tedoldi, F | 1 |
| Chatterjee, AR; Roberts, DR | 1 |
| Chen, S; Hwang, DW; Li, H; Liu, M; Xie, J; Yang, Y; Yuan, Y; Zhang, A; Zhang, Z; Zhou, X | 1 |
| Gao, J; Huang, J; Li, A; Lin, H; Richmond, J; Sun, C; Yang, Z | 1 |
| Andriana, P; Hanaoka, H; Kameo, S; Kartamihardja, AAP; Koyama, H; Takahashi, A; Tsushima, Y | 1 |
| Endrikat, J; Frenzel, T; Jost, G; Noebauer-Huhmann, IM; Pietsch, H; Rohrer, M; Szomolanyi, P; Trattnig, S | 1 |
| Hartman, RP; Hunt, CH; Kallmes, DF; Kolbe, AB; Maddox, DE; McDonald, JS; McDonald, RJ; Schmitz, JJ | 1 |
| Allémann, E; Babič, A; Crowe, LA; Helm, L; Lenglet, S; Thomas, A; Vallée, JP; Van De Looij, Y; Vorobiev, V | 1 |
| Caravan, P; Erstad, DJ; Fuchs, BC; Gale, EM; Jordan, VC; Ramsay, IA; Sojoodi, M; Tanabe, KK | 1 |
| Feng, Y; Gao, M; Jin, Q; Ni, Y; Wu, T; Yin, Z; Zhang, D; Zhang, J; Zhang, L | 1 |
| Tweedle, MF | 1 |
| Davenport, MS; Gagnier, JJ; MacEachern, MP; Shankar, PR; Singer, L; Woolen, SA | 1 |
| Aid-Launais, R; Chaubet, F; Chauvierre, C; Forero Ramirez, LM; Gobin, E; Journe, C; Le Cerf, D; Letourneur, D; Moraes, FC; Picton, L | 1 |
| Contro, J; Narayana, PA; Nery, JG; Santisteban, OAN; Silva, DA | 1 |
| Dodd, S; Koretsky, AP; Pothayee, N; Sail, D; Swenson, RE | 1 |
| Laney, V; Li, Y; Lu, ZR | 1 |
| Chen, K; Luo, Y; Xie, L; Xu, L; Yang, X; Yu, C; Zhang, J | 1 |
| Bonafè, R; Bussi, S; Coppo, A; Kirchin, MA; Maisano, F; Queliti, R; Tedoldi, F | 1 |
| Ai, H; Cai, Z; Du, L; Fu, S; Fu, X; Gong, Q; Liu, L; Lui, S; Song, B; Wu, C; Xia, C | 1 |
| Froehlich, JM; Guirguis, N; Gutzeit, A; Koh, DM; Kolokythas, O; Matoori, S; Moussa, L; Sartoretti-Schefer, S; Wu, D | 1 |
| Huynh, PT; Jung, H; Kim, HS; Ryu, J; Vu, HD; Youn, SW | 1 |
| Homayonia, S; Jalilehvand, F; Ling, CC; Zhang, P | 1 |
7 review(s) available for gadolinium and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
| Article | Year |
|---|---|
Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1990 |
Magnetic resonance imaging of liver tumors.
Topics: Adenoma, Bile Duct; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1989 |
Contrast-enhanced MR imaging of the kidneys and adrenal glands.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1996 |
Interaction of Gd(III) MRI contrast agents with membranes: a review of recent EPR studies.
Topics: Chelating Agents; Electromagnetic Fields; Electron Spin Resonance Spectroscopy; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Membrane Lipids; Organometallic Compounds; Pentetic Acid; Spectrophotometry; Spin Labels; Temperature | 1999 |
MR imaging of the breast: indications, established technique, and new directions.
Topics: Breast; Breast Neoplasms; Contrast Media; Female; Forecasting; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Sensitivity and Specificity | 2003 |
MRI for the evaluation of gastric physiology.
Topics: Contrast Media; Dyspepsia; Gadolinium; Gastric Emptying; Gastrointestinal Motility; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Stomach | 2010 |
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.
Topics: Contraindications, Drug; Contrast Media; Gadolinium; Glomerular Filtration Rate; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Risk; Severity of Illness Index; United States; United States Food and Drug Administration | 2020 |
1 trial(s) available for gadolinium and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
| Article | Year |
|---|---|
Gadolinium-DOTA enhanced MR imaging of prostatic lesions. Preliminary results on 14 cases.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis | 1992 |
162 other study(ies) available for gadolinium and gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
| Article | Year |
|---|---|
Nuclear magnetic relaxation dispersion profiles of aqueous solutions of a series of Gd(NOTA) analogs.
Topics: Aza Compounds; Chelating Agents; Contrast Media; Edetic Acid; Electron Spin Resonance Spectroscopy; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Organometallic Compounds; Organophosphorus Compounds; Pentetic Acid; Structure-Activity Relationship | 1992 |
In vivo dynamic MR imaging of MBP-induced acute experimental allergic encephalomyelitis in Lewis rat.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Myelin Basic Protein; Organometallic Compounds; Rats; Rats, Inbred Lew; Time Factors | 1992 |
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |
Dissociation of gadolinium chelates in mice: relationship to chemical characteristics.
Topics: Animals; Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Male; Mice; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1992 |
Swollen lower extremity: role of MR imaging.
Topics: Adolescent; Adult; Contrast Media; Diagnosis, Differential; Edema; Fats; Female; Gadolinium; Heterocyclic Compounds; Humans; Leg; Lymphedema; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Varicose Veins; Venous Insufficiency | 1992 |
[Cervical carcinoma staging with magnetic resonance tomography: the use of gadolinium-DOTA with 31 patients].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Contrast Media; Evaluation Studies as Topic; Female; Gadolinium; Heterocyclic Compounds; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Organometallic Compounds; Retrospective Studies; Uterine Cervical Neoplasms | 1991 |
Gd-DOTA-enhanced MR imaging and color Doppler US of renal allograft necrosis.
Topics: Adult; Aged; Color; Contrast Media; Doppler Effect; Female; Gadolinium; Graft Rejection; Heterocyclic Compounds; Humans; Image Enhancement; Infarction; Kidney; Kidney Cortex Necrosis; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Organometallic Compounds; Thrombosis; Ultrasonography | 1992 |
Imaging of chordomas of the mobile spine.
Topics: Adult; Aged; Biopsy; Cervical Vertebrae; Chelating Agents; Chordoma; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 1991 |
Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
Topics: Animals; Contrast Media; Dogs; Gadolinium; Heterocyclic Compounds; Kidney; Magnetic Resonance Imaging; Organometallic Compounds; Time Factors | 1991 |
Gd-DTPA and Gd-DOTA effects on metabolism of glucose and phosphatidylinositols.
Topics: Animals; Brain; Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Glucose; Heterocyclic Compounds; Hippocampus; In Vitro Techniques; Male; Organometallic Compounds; Pentetic Acid; Phosphatidylinositols; Rats; Rats, Inbred Strains; Synaptosomes | 1991 |
Blood-pool magnetic resonance imaging contrast agents. New developments.
Topics: Animals; Chromium Radioisotopes; Contrast Media; Drug Evaluation, Preclinical; Drug Stability; Erythrocyte Aging; Erythrocytes; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mice; Organometallic Compounds; Radionuclide Imaging | 1991 |
A new macrocyclic MRI contrast agent: Gd MCTA complex.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds | 1991 |
Gd HP-DO3A--experimental evaluation in brain and renal MR.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Image Enhancement; Kidney; Kidney Cortex; Kidney Medulla; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Models, Structural; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Time Factors | 1991 |
Renal tolerance of the paramagnetic contrast medium Gd-DOTA in patients with chronic renal failure.
Topics: Contrast Media; Drug Tolerance; Gadolinium; Heterocyclic Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organometallic Compounds | 1990 |
Adrenoleukodystrophy. Value of contrast-enhanced MR imaging.
Topics: Adrenoleukodystrophy; Child; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Iodine; Magnetic Resonance Imaging; Male; Organometallic Compounds; Radiographic Image Enhancement; Tomography, X-Ray Computed | 1990 |
MR imaging of the knee in acute rheumatoid arthritis: synovial uptake of gadolinium-DOTA.
Topics: Adult; Aged; Arthritis, Rheumatoid; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Knee; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Synovial Membrane | 1990 |
MRI findings in tuberculous meningo-encephalitis.
Topics: Adolescent; Adult; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Tuberculosis, Meningeal | 1990 |
[Gd-DOTA in musculoskeletal diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Diseases; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscular Diseases; Organometallic Compounds | 1990 |
Tolerance of extracellular contrast agents for magnetic resonance imaging.
Topics: Animals; Contrast Media; Drug Combinations; Drug Tolerance; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats | 1990 |
Paramagnetic liposomes as magnetic resonance contrast agents.
Topics: Animals; Drug Carriers; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Male; Mice; Organometallic Compounds; Pentetic Acid; Rats | 1990 |
The use of Gd-DOTA in magnetic resonance imaging of experimentally induced mammary tumors.
Topics: Adenocarcinoma; Animals; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Organometallic Compounds; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Renal handling and physiologic effects of the paramagnetic contrast medium Gd-DOTA.
Topics: Animals; Blood Pressure; Contrast Media; Dogs; Female; Gadolinium; Glomerular Filtration Rate; Heterocyclic Compounds; Injections, Intravenous; Kidney; Magnetic Resonance Imaging; Male; Organometallic Compounds; Renal Circulation | 1990 |
Gd-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers.
Topics: Adult; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Tissue Distribution | 1990 |
Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Kidney Medulla; Magnetic Resonance Imaging; Male; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344 | 1989 |
A case of intracranial chordoma investigated by MRI and CT studies.
Topics: Aged; Brain Neoplasms; Chordoma; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Tomography, X-Ray Computed | 1989 |
MR imaging of the brain: preliminary results with a gradient echo sequence after paramagnetic contrast enhancement.
Topics: Brain Diseases; Brain Neoplasms; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds; Time Factors | 1989 |
Action of gadolinium complexes on different enzyme systems.
Topics: Animals; Brain; Choline O-Acetyltransferase; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Glutamate Decarboxylase; Heterocyclic Compounds; In Vitro Techniques; Organometallic Compounds; Pentetic Acid; Rats | 1986 |
Brain distribution of MRI contrast media in rats after intracisternal injection.
Topics: Animals; Brain; Cisterna Magna; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1987 |
The importance of nuclear magnetic relaxation dispersion (NMRD) profiles in MRI contrast media development.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1988 |
Gd-DOTA, a potential MRI contrast agent. Current status of physicochemical knowledge.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Structure-Activity Relationship | 1988 |
[Contribution of gadolinium DOTA in primary tumors of bone and soft tissue].
Topics: Adult; Aged; Bone Neoplasms; Evaluation Studies as Topic; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Soft Tissue Neoplasms | 1988 |
Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
Topics: Acetates; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Male; Mice; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1988 |
Gd-DOTA: characterization of a new paramagnetic complex.
Topics: Animals; Chemical Phenomena; Chemistry; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetics; Mice; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains; Tissue Distribution | 1988 |
Considerations in the choice of contrast media for MR imaging.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1988 |
[In vitro study of the action of DOTA and DTPA-gadolinium complexes on platelet functions: aggregation and calcium excretion].
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Calcium; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; In Vitro Techniques; Male; Organometallic Compounds; Pentetic Acid; Platelet Aggregation | 1988 |
MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
Topics: Animals; Brain Neoplasms; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1988 |
Subcellular localisation of gadolinium in the rat brain.
Topics: Animals; Brain; Contrast Media; Gadolinium; Heterocyclic Compounds; Male; Organometallic Compounds; Rats; Subcellular Fractions | 1987 |
Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Spectroscopy; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid; Spectrum Analysis | 1986 |
[Imagery of human immunodeficiency virus (HIV) encephalitis].
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Atrophy; Brain Neoplasms; Contrast Media; Cytomegalovirus Infections; Encephalitis, Viral; Female; Gadolinium; Heterocyclic Compounds; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, AIDS-Related; Magnetic Resonance Imaging; Male; Organometallic Compounds; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1995 |
MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Chelating Agents; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Hemangioma, Cavernous; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Observer Variation; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity; Statistics, Nonparametric | 1995 |
Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Topics: Animals; Calcium; Chelating Agents; Contrast Media; Excipients; Femur; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections, Intravenous; Liver; Male; Mice; Organometallic Compounds; Pentetic Acid; Radioisotopes; Rats; Time Factors; Tissue Distribution | 1995 |
Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter.
Topics: Adult; Brain Chemistry; Choline; Contrast Media; Creatine; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Phosphocreatine | 1995 |
Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Dysprosium; Gadolinium; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar; Time Factors | 1995 |
Interaction of gadolinium complexes with metal-dependent biological systems.
Topics: Cell Division; Cells, Cultured; Chlorides; Contrast Media; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid; Peptidyl-Dipeptidase A; Zinc Compounds | 1994 |
Dynamic Gd-DOTA-enhanced MR imaging of hepatic metastases from pancreatic neuroendocrine tumors.
Topics: Adult; Aged; Carcinoid Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Gastrinoma; Heterocyclic Compounds; Humans; Image Enhancement; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Prospective Studies; Retrospective Studies; Vipoma | 1994 |
Pituitary microadenomas: experience with Gd-DOTA-enhanced MR imaging at 0.5 Telsa.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Contrast Media; Female; Gadolinium; Hemorrhage; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Sella Turcica | 1994 |
Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement.
Topics: Albumins; Animals; Body Water; Contrast Media; Dose-Response Relationship, Drug; Echo-Planar Imaging; Female; Gadolinium; Gadolinium DTPA; Half-Life; Heart Ventricles; Heterocyclic Compounds; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Myocardium; Organometallic Compounds; Pentetic Acid; Polylysine; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1994 |
Diagnosis of bronchial carcinoid tumor by ultrafast contrast-enhanced MR imaging.
Topics: Bronchi; Bronchial Neoplasms; Carcinoid Tumor; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds | 1994 |
Relaxometry, animal biodistribution, and magnetic resonance imaging studies of some new gadolinium (III) macrocyclic phosphinate and phosphonate monoester complexes.
Topics: Animals; Contrast Media; Ethylenediamines; Gadolinium; Heterocyclic Compounds; Organometallic Compounds; Phosphorous Acids; Rabbits; Radioisotopes; Rats; Rats, Sprague-Dawley; Samarium | 1993 |
Recurrent bone neoplasm and spiral bladder pattern on pelvic MRI.
Topics: Bone Neoplasms; Contrast Media; Gadolinium; Hemipelvectomy; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pelvic Neoplasms; Urinary Bladder | 1993 |
Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
Topics: Contrast Media; Drug Stability; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid | 1994 |
Hepatic metastases: detection with multisection FLASH MR imaging during gadolinium chelate-enhanced arterial portography.
Topics: Adult; Aged; Chelating Agents; Contrast Media; Feasibility Studies; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Portography; Prospective Studies; Sensitivity and Specificity | 1993 |
Contrast-enhanced magnetic resonance tomoangiography: a new imaging technique for studying thoracic great vessels.
Topics: Aorta; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pulmonary Artery; Pulmonary Embolism | 1993 |
Complementary use of T2- and postcontrast T1-weighted NMR images for the sequential monitoring of focal ischemic lesions in the rat brain.
Topics: Animals; Cerebral Infarction; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Male; Monitoring, Physiologic; Organometallic Compounds; Rats; Rats, Wistar; Time Factors | 1993 |
[Abdominal tumors in children. A comparison between magnetic resonance tomography (MRT) and ultrasonography (US)].
Topics: Abdomen; Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Gadolinium; Heterocyclic Compounds; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Organometallic Compounds; Ultrasonography | 1993 |
Magnetic resonance image appearance of hamartoma of the breast.
Topics: Adult; Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium; Hamartoma; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds | 1993 |
MRI in craniofacial fibrous dysplasia.
Topics: Adolescent; Adult; Contrast Media; Facial Bones; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Monostotic; Fibrous Dysplasia, Polyostotic; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Jaw Diseases; Magnetic Resonance Imaging; Middle Aged; Orbital Diseases; Organometallic Compounds; Skull; Sphenoid Bone; Temporal Bone | 1993 |
Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.
Topics: Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Organometallic Compounds; Prospective Studies; Spinal Neoplasms; Spine | 1993 |
MR appearance of multiple myeloma of the spine before and after treatment.
Topics: Combined Modality Therapy; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Organometallic Compounds; Prospective Studies; Spinal Neoplasms; Spine | 1993 |
MRI of acoustic schwannoma: a retrospective study of 89 tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroma, Acoustic; Organometallic Compounds; Pentetic Acid; Retrospective Studies | 1993 |
Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Solitary Pulmonary Nodule | 1996 |
Standard and high resolution magnetic resonance imaging of glomus tumors of toes and fingertips.
Topics: Adolescent; Adult; Bone and Bones; Contrast Media; Female; Fingers; Foot Diseases; Gadolinium; Glomus Tumor; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Nail Diseases; Organometallic Compounds; Toes | 1996 |
Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation.
Topics: Aged; Carcinoma; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Laser Therapy; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prostate; Prostatectomy; Prostatic Neoplasms | 1997 |
1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.
Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Fourier Analysis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hydrogen; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid; Regression Analysis | 1997 |
Non-breath-hold fast spin-echo versus breath-hold fast spin-echo and spoiled gradient-recalled echo MR imaging in the detection of hepatic tumors: correlation with surgical findings.
Topics: Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 1997 |
Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Topics: Animals; Contrast Media; Dextrans; Gadolinium; Heterocyclic Compounds; Lethal Dose 50; Magnetic Resonance Imaging; Male; Mice; Molecular Weight; Organometallic Compounds; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship; Tissue Distribution | 1997 |
Noninvasive stress testing of myocardial ischemia: comparison of GRE-MRI perfusion and wall motion analysis to 99 mTc-MIBI-SPECT, relation to coronary angiography.
Topics: Contrast Media; Coronary Angiography; Coronary Circulation; Dipyridamole; Electrocardiography; Feasibility Studies; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Organometallic Compounds; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1997 |
Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
Topics: Animals; Blood Pressure; Calcium; Chelating Agents; Contrast Media; Diltiazem; Gadolinium; Gadolinium DTPA; Hemodynamics; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Phentolamine; Rats; Rats, Sprague-Dawley | 1998 |
Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Contrast Media; Cricetinae; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Urinary Bladder; Urinary Bladder Neoplasms | 1998 |
Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Diagnosis, Differential; False Positive Reactions; Female; Fibroadenoma; Gadolinium; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 1998 |
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.
Topics: Contrast Media; Drug Carriers; Emulsions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Lipids; Magnetic Resonance Spectroscopy; Microspheres; Organometallic Compounds | 1998 |
Intradural extramedullary spinal canal secondary neoplasms: MR findings in 30 patients.
Topics: Breast Neoplasms; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Spinal Cord; Spinal Cord Neoplasms | 1998 |
Multinuclear magnetic resonance characterization of paramagnetic contrast agents. The manifold effects of concentration and counterions.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Spectroscopy; Organometallic Compounds | 1998 |
Patterns of framework invasion in patients with laryngeal cancer: correlation of in vitro magnetic resonance imaging and pathological findings.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; False Negative Reactions; False Positive Reactions; Gadolinium; Heterocyclic Compounds; Humans; Laryngeal Cartilages; Laryngeal Neoplasms; Laryngectomy; Laryngoscopy; Laser Therapy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Voice | 1998 |
Gadolinium chelate-enhanced subtraction spoiled gradient-recalled echo MR imaging of hepatic tumors.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Subtraction Technique | 1999 |
Assessment of gastric motor function during the emptying of solid and liquid meals in humans by MRI.
Topics: Adult; Contrast Media; Female; Food; Gadolinium; Gastric Emptying; Gastrointestinal Motility; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds | 1999 |
Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Macromolecular Substances; Organometallic Compounds | 1999 |
Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.
Topics: Animals; Brain; Contrast Media; Dextrans; Encephalomyelitis, Autoimmune, Experimental; Female; Ferrosoferric Oxide; Gadolinium; Heterocyclic Compounds; Immunohistochemistry; Iron; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Rats; Rats, Inbred Lew; Sensitivity and Specificity | 1999 |
Assessment of iron oxide particles (AMI 227) and a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) in a tumor model implanted in rats.
Topics: Animals; Contrast Media; Dextrans; Echo-Planar Imaging; Feasibility Studies; Ferrosoferric Oxide; Gadolinium; Heterocyclic Compounds; Hindlimb; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Neoplasm Transplantation; Organometallic Compounds; Oxides; Rats; Rats, Wistar; Rhabdomyosarcoma | 1999 |
Gd-BOPTA: "the MRA contrast agent of choice"?
Topics: Aortic Valve Stenosis; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Subclavian Artery; Vascular Diseases | 1999 |
Faecal tagging to avoid colonic cleansing before MRI colonography.
Topics: Colon; Colonic Polyps; Contrast Media; Enema; Feasibility Studies; Feces; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Patient Acceptance of Health Care | 1999 |
Dynamic magnetic resonance imaging of head and neck lesions.
Topics: Algorithms; Contrast Media; Factor Analysis, Statistical; Gadolinium; Gadolinium DTPA; Head and Neck Neoplasms; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds | 1999 |
Pilot MR evaluation of pharmacokinetics and relaxivity of specific blood pool agents for MR angiography.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Organometallic Compounds; Pilot Projects; Rabbits | 2000 |
Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Male; Organometallic Compounds; Rabbits | 2000 |
Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction.
Topics: Adult; Blood Volume; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds | 2000 |
In vivo microscopic evaluation of the microvascular behavior of FITC-labeled macromolecular MR contrast agents in the hamster skinfold chamber.
Topics: Animals; Capillary Permeability; Contrast Media; Cricetinae; Extravasation of Diagnostic and Therapeutic Materials; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Melanoma, Amelanotic; Melanoma, Experimental; Microcirculation; Microscopy, Fluorescence; Organometallic Compounds; Random Allocation; Skin Neoplasms; Time Factors; Video Recording | 2000 |
Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model.
Topics: Animals; Ascitic Fluid; Contrast Media; Diffusion; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Models, Biological; Organometallic Compounds | 2001 |
P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Indicators and Reagents; Lethal Dose 50; Magnetic Resonance Imaging; Male; Metabolic Clearance Rate; Molecular Structure; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution | 2001 |
A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: kinetic study on a C6 rat glioma model.
Topics: Animals; Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2001 |
Assessment of hepatic perfusion parameters with dynamic MRI.
Topics: Animals; Computer Simulation; Contrast Media; Gadolinium; Heterocyclic Compounds; Liver; Liver Circulation; Magnetic Resonance Imaging; Male; Microspheres; Organometallic Compounds; Rabbits | 2002 |
MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits.
Topics: Animals; Aorta, Abdominal; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Organometallic Compounds; Phantoms, Imaging; Rabbits | 2002 |
Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition.
Topics: Cells, Cultured; Contrast Media; Dextrans; Electrochemistry; Ferrosoferric Oxide; Gadolinium; Heterocyclic Compounds; Hydrogen-Ion Concentration; Iron; Lipids; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Transfection | 2003 |
Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system.
Topics: Binding Sites; Chelating Agents; Crystallography, X-Ray; Gadolinium; Heterocyclic Compounds; Hydrophobic and Hydrophilic Interactions; Immunoglobulin Fragments; Isomerism; Models, Molecular; Organometallic Compounds; Yttrium | 2003 |
Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI.
Topics: Adult; Aorta, Abdominal; Calibration; Computer Simulation; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Hypertension, Portal; Image Enhancement; Linear Models; Liver; Liver Circulation; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Models, Biological; Organometallic Compounds; Phantoms, Imaging; Portal System; Portal Vein; Reproducibility of Results | 2004 |
Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Temperature | 2004 |
Magnetic resonance imaging of myocardial perfusion and viability using a blood pool contrast agent.
Topics: Animals; Contrast Media; Coronary Circulation; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Myocardial Infarction; Myocardium; Organometallic Compounds; Swine | 2004 |
Myometrial invasion and cervical invasion by endometrial carcinoma: evaluation by CO2-volumetric interpolated breathhold examination (VIBE).
Topics: Aged; Carbon Dioxide; Carcinoma, Adenosquamous; Carcinoma, Endometrioid; Contrast Media; Endometrial Neoplasms; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Insufflation; Magnetic Resonance Imaging; Middle Aged; Myometrium; Neoplasm Invasiveness; Neoplasm Staging; Organometallic Compounds; Uterine Cervical Neoplasms | 2005 |
Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Image Enhancement; Kidney; Kidney Glomerulus; Kidney Medulla; Kidney Pelvis; Magnetic Resonance Imaging; Male; Organometallic Compounds; Phantoms, Imaging; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Contrast-enhanced dynamic MRI protocol with improved spatial and time resolution for in vivo microimaging of the mouse with a 1.5-T body scanner and a superconducting surface coil.
Topics: Animals; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Organometallic Compounds; Sensitivity and Specificity | 2005 |
Dose optimization of contrast-enhanced carotid MR angiography.
Topics: Adult; Aged; Aged, 80 and over; Carotid Arteries; Carotid Stenosis; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Stroke | 2005 |
MAGfect: a novel liposome formulation for MRI labelling and visualization of cells.
Topics: Cells; DNA; Gadolinium; HeLa Cells; Heterocyclic Compounds; Humans; Lipids; Liposomes; Magnetic Resonance Spectroscopy; Organometallic Compounds; Plasmids; Staining and Labeling; Transfection | 2006 |
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.
Topics: Animals; Contrast Media; Fluorescence; Gadolinium; Heterocyclic Compounds; Liver; Lung; Magnetic Resonance Imaging; Mice; Mice, Nude; Nanoparticles; Organometallic Compounds; Polyethylene Glycols; Rats; Siloxanes | 2007 |
Pharmacokinetic modeling of dynamic contrast-enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-alpha therapy.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Metacarpophalangeal Joint; Models, Biological; Organometallic Compounds; Reproducibility of Results; Synovial Membrane; Synovitis; Treatment Outcome; Tumor Necrosis Factor-alpha; Wrist Joint | 2007 |
New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues.
Topics: Animals; Breast Neoplasms; Contrast Media; Endothelium, Vascular; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Rats; Rats, Nude; Transplantation, Heterologous | 2008 |
Stability of gadolinium chelates and their biological consequences: new data and some comments.
Topics: Animals; Contrast Media; Drug Stability; Gadolinium; Gadolinium DTPA; Half-Life; Heterocyclic Compounds; Mice; Organometallic Compounds | 2008 |
EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
Topics: Contrast Media; Fibrin; Fibrinogen; Gadolinium; Heterocyclic Compounds; Humans; Kinetics; Magnetic Resonance Angiography; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Peptides; Protein Binding; Substrate Specificity; Thermodynamics; Thrombosis | 2008 |
Synthesis of multimeric MR contrast agents for cellular imaging.
Topics: Animals; Biocompatible Materials; Cell Survival; Contrast Media; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; NIH 3T3 Cells; Organometallic Compounds | 2008 |
Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.
Topics: Cell Line, Tumor; Contrast Media; Dopamine; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Nanostructures; Oligonucleotides; Organometallic Compounds; Polyglutamic Acid; Titanium | 2008 |
Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Topics: Amides; Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Mice; Mice, Nude; Molecular Conformation; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds | 2008 |
Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
Topics: Animals; Brain Neoplasms; Cell Membrane Permeability; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Glioma; Heterocyclic Compounds; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Microvessels; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Wistar | 2009 |
Gadoteridol-induced anaphylaxis - not a class allergy.
Topics: Aged; Anaphylaxis; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hypersensitivity; Male; Meglumine; Organometallic Compounds; Skin Tests | 2010 |
Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI.
Topics: Adult; Aged; Contrast Media; Electrocardiography; Female; Gadolinium; Heart Ventricles; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Stroke Volume; Ventricular Function, Left | 2009 |
Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI.
Topics: Animals; Contrast Media; Ear, Inner; Female; Gadolinium; Heterocyclic Compounds; Humans; Imaging, Three-Dimensional; Injections, Intravenous; Magnetic Resonance Imaging; Mice; Mice, Inbred Strains; Models, Animal; Organometallic Compounds; Perilymph; Tympanic Membrane | 2010 |
Densely packed Gd(III)-chelates with fast water exchange on a calix[4]arene scaffold: a potential MRI contrast agent.
Topics: Animals; Calixarenes; Cattle; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Micelles; Models, Molecular; Organometallic Compounds; Phenols; Protein Binding; Serum Albumin, Bovine; Water | 2010 |
Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.
Topics: Chelating Agents; Chromatography, High Pressure Liquid; Contrast Media; Dendrimers; Gadolinium; Heterocyclic Compounds; Hydrogen-Ion Concentration; Ligands; Magnetic Resonance Imaging; Organometallic Compounds; Polyamines; Spectrophotometry, Ultraviolet; Temperature | 2010 |
pH-Dependent biodegradable silica nanotubes derived from Gd(OH)3 nanorods and their potential for oral drug delivery and MR imaging.
Topics: Administration, Oral; Biocompatible Materials; Camptothecin; Drug Delivery Systems; Gadolinium; HeLa Cells; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Hydroxides; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Nanotubes; Organometallic Compounds; Silicon Dioxide; Temperature; Time Factors | 2010 |
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
Topics: Adult; Cell Proliferation; Collagen; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hyaluronic Acid; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds | 2010 |
A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Folate Receptors, GPI-Anchored; Folic Acid; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Weight; Organometallic Compounds; Spectrophotometry, Atomic; Staining and Labeling | 2011 |
Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model.
Topics: Animals; Chromatography, High Pressure Liquid; Contrast Media; Feasibility Studies; Fibrin; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Mass Spectrometry; Organometallic Compounds; Peptides; Positron-Emission Tomography; Rats; Thrombosis | 2011 |
Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
Topics: Albumins; Animals; Contrast Media; Coordination Complexes; Dendrimers; Female; Gadolinium; Heterocyclic Compounds; Jugular Veins; Magnetic Resonance Imaging; Mice; Mice, Nude; Organometallic Compounds; Radionuclide Imaging | 2011 |
Diamagnetically trapped arrays of living cells above micromagnets.
Topics: Cell Culture Techniques; Cell Growth Processes; Cell Survival; Contrast Media; Equipment Design; Gadolinium; Heterocyclic Compounds; Humans; Jurkat Cells; Magnets; Meglumine; Organometallic Compounds; Tissue Array Analysis | 2011 |
Dynamic enhancement of the rat inner ear after ultra-small-volume administration of Gd-DOTA to the medial wall of the middle ear cavity.
Topics: Animals; Contrast Media; Disease Models, Animal; Ear Diseases; Ear, Inner; Ear, Middle; Gadolinium; Heterocyclic Compounds; Injections; Magnetic Resonance Imaging; Male; Organometallic Compounds; Rats; Rats, Wistar; Reproducibility of Results | 2011 |
The use of magnetic resonance cell tracking to monitor endothelial progenitor cells in a rat hindlimb ischemic model.
Topics: Animals; Cell Movement; Cell Tracking; Dextrans; Disease Models, Animal; Endothelial Cells; Gadolinium; Heterocyclic Compounds; Hindlimb; Imaging, Three-Dimensional; Ischemia; Magnetic Resonance Spectroscopy; Male; Organometallic Compounds; Rats; Rats, Inbred F344; Regional Blood Flow; Stem Cell Transplantation; Stem Cells; Wound Healing | 2012 |
Small bowel enteroclysis with magnetic resonance imaging and computed tomography in patients with failed and uncertain passage of a patency capsule.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capsule Endoscopy; Capsules; Child; Contrast Media; Crohn Disease; Female; Gadolinium; Heterocyclic Compounds; Humans; Intestine, Small; Iohexol; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Polyethylene Glycols; Tomography, X-Ray Computed; Young Adult | 2012 |
Synthesis and characterization of a hypoxia-sensitive MRI probe.
Topics: Animals; Gadolinium; Heterocyclic Compounds; Hypoxia; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Organometallic Compounds; Rats | 2012 |
Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Topics: Animals; Cell Line; Cell Line, Tumor; Contrast Media; Gadolinium; HeLa Cells; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Xenograft Model Antitumor Assays | 2012 |
Glycogen as a biodegradable construction nanomaterial for in vivo use.
Topics: Animals; Biocompatible Materials; Drug Delivery Systems; Fluorescence; Gadolinium; Glycogen; Heterocyclic Compounds; Microscopy, Electron, Transmission; Molecular Imaging; Nanostructures; Organometallic Compounds | 2012 |
Tumor targeting and MR imaging with lipophilic cyanine-mediated near-infrared responsive porous Gd silicate nanoparticles.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Endocytosis; Fibroblasts; Fluorescence; Gadolinium; Heterocyclic Compounds; Humans; Indocyanine Green; Lipids; Magnetic Resonance Imaging; Mice; Mice, SCID; Nanoparticles; Neoplasms; Organ Specificity; Organometallic Compounds; Porosity; Propylamines; Silanes; Silicates; Spectroscopy, Near-Infrared; Time Factors | 2013 |
Imaging new lesions: enhancing our understanding of multiple sclerosis pathogenesis.
Topics: Brain; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds | 2013 |
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
Topics: Adult; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds | 2013 |
Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents.
Topics: Amino Acid Sequence; Collagen; Contrast Media; Fibrin; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Molecular Sequence Data; Organometallic Compounds; Peptides; Staining and Labeling; Structure-Activity Relationship | 2014 |
Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI.
Topics: Animals; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Contrast Media; Creatinine; Female; Gadolinium; Heterocyclic Compounds; Inflammation; Kidney; Lipopolysaccharides; Lung; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Nanomedicine; Nanoparticles; Optics and Photonics; Organometallic Compounds; Time Factors; Tissue Distribution | 2014 |
Stabilized porous liposomes with encapsulated Gd-labeled dextran as a highly efficient MRI contrast agent.
Topics: Contrast Media; Dextrans; Fluorescein-5-isothiocyanate; Gadolinium; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Organometallic Compounds; Phosphatidylcholines; Porosity | 2014 |
In vivo immunotoxicity of SiO2@(Y0.5Gd0.45Eu0.05)2O3 as dual-modality nanoprobes.
Topics: Animals; Apoptosis; Biocompatible Materials; Cell Line; Europium; Gadolinium; Heterocyclic Compounds; Immune System; Interleukin-2 Receptor alpha Subunit; Interleukin-4; Lectins, C-Type; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; Nanocomposites; Neutrophils; Organometallic Compounds; Oxides; Reactive Oxygen Species; Receptors, Cell Surface; Silicon Dioxide; Tissue Distribution; Yttrium | 2014 |
Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
Topics: Animals; Cell Line, Tumor; Chromatography, High Pressure Liquid; Contrast Media; Cycloparaffins; Female; Gadolinium; Heterocyclic Compounds; Humans; Integrins; Kidney; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oligopeptides; Organometallic Compounds; Protein Binding; Urinary Bladder | 2014 |
A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent.
Topics: Animals; Contrast Media; Coordination Complexes; Fullerenes; Gadolinium; Heart; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Radiography; Rats; Rats, Sprague-Dawley | 2015 |
Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
Topics: Animals; Chelating Agents; Chemistry, Pharmaceutical; Contrast Media; Femur; Gadolinium; Heterocyclic Compounds; Kidney; Liver; Male; Myocardium; Organometallic Compounds; Rats, Wistar; Renal Insufficiency; Skin | 2015 |
Pulsed EPR spectroscopy distance measurements of DNA internally labelled with Gd(3+)-DOTA.
Topics: Animals; Click Chemistry; Electron Spin Resonance Spectroscopy; Gadolinium; Heterocyclic Compounds; Oligodeoxyribonucleotides; Oocytes; Organometallic Compounds; Spin Labels; Vitelline Membrane; Xenopus laevis | 2015 |
Cationic gadolinium chelate for magnetic resonance imaging of cartilaginous defects.
Topics: Animals; Cartilage; Cations; Cattle; Chelating Agents; Gadolinium; Glycosaminoglycans; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Wounds and Injuries | 2016 |
Overcoming artificial broadening in Gd(3+)-Gd(3+) distance distributions arising from dipolar pseudo-secular terms in DEER experiments.
Topics: Algorithms; Bacteriophage T4; Cations; Contrast Media; Electron Spin Resonance Spectroscopy; Equipment Design; Gadolinium; Heterocyclic Compounds; Models, Molecular; Muramidase; Organometallic Compounds | 2016 |
Alkaline Phosphatase-Instructed Self-Assembly of Gadolinium Nanofibers for Enhanced T
Topics: Alkaline Phosphatase; Animals; Contrast Media; Gadolinium; HeLa Cells; Heterocyclic Compounds; Humans; Hydrogels; Magnetic Resonance Imaging; Mice, Inbred BALB C; Nanofibers; Neoplasms; Oligopeptides; Organometallic Compounds; Phantoms, Imaging | 2017 |
Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
Topics: Animals; Brain; Contrast Media; Femur; Gadolinium; Heterocyclic Compounds; Kidney; Liver; Male; Models, Animal; Organometallic Compounds; Rats; Rats, Wistar; Skin | 2018 |
The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body.
Topics: Animal Experimentation; Animals; Brain; Child; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Organometallic Compounds; Rats | 2019 |
Engineered Paramagnetic Graphene Quantum Dots with Enhanced Relaxivity for Tumor Imaging.
Topics: Chelating Agents; Contrast Media; Gadolinium; Graphite; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Nanostructures; Neoplasms; Organometallic Compounds; Quantum Dots; Water | 2019 |
A gadolinium-complex-based theranostic prodrug for in vivo tumour-targeted magnetic resonance imaging and therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Drug Carriers; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Organometallic Compounds; Prodrugs; Signal-To-Noise Ratio; Theranostic Nanomedicine; Transplantation, Heterologous | 2019 |
Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
Topics: Animals; Brain; Chromatography, Gel; Contrast Media; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Mice; Models, Animal; Organometallic Compounds; Saline Solution | 2019 |
Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 T.
Topics: Blood; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Phantoms, Imaging | 2019 |
Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
Topics: Acute Disease; Adult; Aged; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors | 2019 |
Pharmacokinetics and biodistribution study of self-assembled Gd-micelles demonstrating blood-pool contrast enhancement for MRI.
Topics: Animals; Cell Survival; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; MCF-7 Cells; Mice, Inbred BALB C; Micelles; Organometallic Compounds; Tissue Distribution | 2019 |
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Topics: Animals; Breast Neoplasms; Contrast Media; Diamines; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Manganese Compounds; Mice; Mice, Inbred BALB C; Organometallic Compounds; Picolinic Acids; Tissue Distribution | 2019 |
Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
Topics: Animals; Anthraquinones; Catheter Ablation; Contrast Media; Gadolinium; Hep G2 Cells; Heterocyclic Compounds; Humans; Hyperthermia, Induced; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Microwaves; Necrosis; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Solvents; Treatment Outcome | 2019 |
Next-Generation MRI Contrast Agents: Still Including Gadolinium.
Topics: Brain Neoplasms; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds | 2020 |
Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets.
Topics: Adult; Blood Platelets; Cells, Cultured; Contrast Media; Cross-Linking Reagents; Dextrans; Emulsions; Gadolinium; Healthy Volunteers; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Nanoparticles; Organometallic Compounds; Particle Size; Platelet Activation; Polysaccharides; Spectrometry, X-Ray Emission; Thrombosis | 2020 |
In vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applications.
Topics: Animals; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Zeolites | 2021 |
Multivalent Gd-DOTA Decorated Oligopeptide as Sensitive MRI Molecular Probes for
Topics: Brain; Contrast Media; Diffusion Tensor Imaging; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Manganese; Molecular Probes; Oligopeptides; Organometallic Compounds | 2022 |
Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Topics: Amino Acids; Animals; Contrast Media; Fibrin; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Molecular Imaging; Neoplasms; Oncogene Proteins; Organometallic Compounds; Peptides; Tumor Microenvironment | 2022 |
Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
Topics: Cerebellar Nuclei; Contrast Media; Gadolinium; Gadolinium DTPA; Globus Pallidus; Humans; Magnetic Phenomena; Magnetic Resonance Imaging; Organometallic Compounds; Retrospective Studies | 2023 |
Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?
Topics: Animals; Contrast Media; Creatinine; Gadolinium; Male; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Urea | 2023 |
Gadolinium(III) Complex-Backboned Branched Polymers as Imaging Probes for Contrast-Enhanced Magnetic Resonance Angiography.
Topics: Animals; Chelating Agents; Contrast Media; Gadolinium; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Polymers | 2023 |
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study.
Topics: Bile; Cholangiography; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine | 2023 |
Gadolinium-Cyclic 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Click-Sulfonyl Fluoride for Probing Serine Protease Activity in Magnetic Resonance Imaging.
Topics: Contrast Media; Gadolinium; Magnetic Resonance Imaging; Serine Proteases | 2023 |
Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent.
Topics: beta-Cyclodextrins; Contrast Media; Cyclodextrins; Gadolinium; Ligands; Magnetic Resonance Imaging | 2023 |